Drugs / Plasma-Lyte P
Plasma-Lyte P
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02835157 | Apr 2017 → Jan 2020 | infectious disease with sepsis | All India Institute of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plasma-Lyte P | “a fluid bolus comprising of 'multiple electrolyte solution (Plasma-Lyte P)' solution at a dose of 20 ml/kg over 15-20 minutes” NCT02835157 ↗ |
| Known as | Balanced crystalloid solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02835157 ↗ |
| Known as | MES | “Children were randomized to receive fluid boluses of either MES (PlasmaLyte A) or 0.9% saline at the time of identification of shock.” PMID 37294145 ↗ Jun 2023 |
| Known as | PlasmaLyte A | “Children were randomized to receive fluid boluses of either MES (PlasmaLyte A) or 0.9% saline at the time of identification of shock.” PMID 37294145 ↗ Jun 2023 |